Stittelaar KJ - Search Results

1

Use of cotton rats for preclinical evaluation of measles vaccines.

Wyde PR, Stittelaar KJ, Osterhaus AD, Guzman E, Gilbert BE. Wyde PR, et al. Among authors: stittelaar kj. Vaccine. 2000 Aug 15;19(1):42-53. doi: 10.1016/s0264-410x(00)00151-1. Vaccine. 2000. PMID: 10924785

2

Priming of measles virus-specific humoral- and cellular-immune responses in macaques by DNA vaccination.

Stittelaar KJ, de Swart RL, Vos HW, van Amerongen G, Sixt N, Wild TF, Osterhaus AD. Stittelaar KJ, et al. Vaccine. 2002 May 15;20(16):2022-6. doi: 10.1016/s0264-410x(02)00048-8. Vaccine. 2002. PMID: 11972970

3

Enteric administration of a live attenuated measles vaccine does not induce protective immunity in a macaque model.

Stittelaar KJ, de Swart RL, Vos HW, van Amerongen G, Agafonov AP, Nechaeva EA, Osterhaus AD. Stittelaar KJ, et al. Vaccine. 2002 Jul 26;20(23-24):2906-12. doi: 10.1016/s0264-410x(02)00231-1. Vaccine. 2002. PMID: 12126901

4

Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates.

Stittelaar KJ, Vos HW, van Amerongen G, Kersten GF, Osterhaus AD, de Swart RL. Stittelaar KJ, et al. Vaccine. 2002 Dec 13;21(3-4):155-7. doi: 10.1016/s0264-410x(02)00453-x. Vaccine. 2002. PMID: 12450688

5

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV.

Stittelaar KJ, Gruters RA, Schutten M, van Baalen CA, van Amerongen G, Cranage M, Liljeström P, Sutter G, Osterhaus AD. Stittelaar KJ, et al. Vaccine. 2002 Jul 26;20(23-24):2921-7. doi: 10.1016/s0264-410x(02)00219-0. Vaccine. 2002. PMID: 12126903

6

Vaccination against measles: a neverending story.

Stittelaar KJ, de Swart RL, Osterhaus AD. Stittelaar KJ, et al. Expert Rev Vaccines. 2002 Aug;1(2):151-9. doi: 10.1586/14760584.1.2.151. Expert Rev Vaccines. 2002. PMID: 12901554 Free article. Review.

7

Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques.

Koraka P, Benton S, van Amerongen G, Stittelaar KJ, Osterhaus AD. Koraka P, et al. Among authors: stittelaar kj. Vaccine. 2007 Jul 20;25(29):5409-16. doi: 10.1016/j.vaccine.2007.04.079. Epub 2007 May 21. Vaccine. 2007. PMID: 17560694

8

Measles vaccination: new strategies and formulations.

de Vries RD, Stittelaar KJ, Osterhaus AD, de Swart RL. de Vries RD, et al. Among authors: stittelaar kj. Expert Rev Vaccines. 2008 Oct;7(8):1215-23. doi: 10.1586/14760584.7.8.1215. Expert Rev Vaccines. 2008. PMID: 18844595 Free article. Review.

9

Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets.

Stittelaar KJ, Veldhuis Kroeze EJ, Rudenko L, Dhere R, Thirapakpoomanunt S, Kieny MP, Osterhaus AD. Stittelaar KJ, et al. Vaccine. 2011 Nov 15;29(49):9265-70. doi: 10.1016/j.vaccine.2011.09.049. Epub 2011 Sep 22. Vaccine. 2011. PMID: 21945964

10

In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.

Stittelaar KJ, Boes J, Kersten GF, Spiekstra A, Mulder PG, de Vries P, Roholl PJ, Dalsgaard K, van den Dobbelsteen G, van Alphen L, Osterhaus AD. Stittelaar KJ, et al. Vaccine. 2000 May 22;18(23):2482-93. doi: 10.1016/s0264-410x(00)00026-8. Vaccine. 2000. PMID: 10775782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters